"A great effort must therefore continue to be made to identify new biomarkers, as well as more specific therapeutic targets, in order to reduce the level of toxicity of treatments."
On 6 and 7 March, the Paranimf at the University of Barcelona Faculty of Medicine will be hosting some of the world's most renowned experts on tumour clonal heterogeneity.
• Con motivo del Día Mundial de las Enfermedades Raras (28 de febrero), el Instituto de Investigación contra la Leucemia Josep Carreras presenta una nueva línea de trabajo exclusivamente centrada en las anemias minoritarias.
• El 80% de las anemias minoritarias son diagnosticadas en los primeros años de vida lo que supone que apunten a enfermedades que afectan eminentemente a los niños. Son enfermedades graves y de muy difícil diagnóstico.
"As we understand more and more about the genetic basis and other aspects of the pathogenesis of lymphomas, we will be able to establish more precise and less toxic, more biologically oriented drugs that might have fewer side effects compared to standard chemotherapy."
Josep Carreras raises more than three million euros for the fight against leukaemia in the 22nd TV Gala in Germany.
• Dr. Albert Oriol, a hematologist at the Catalan Institute of Oncology/Germans Trias i Pujol Hospital, and researcher at the Josep Carreras Leukaemia Research Institute, takes part in an international study to assess a promising combination of drugs in the treatment of multiple myeloma.
• Multiple myeloma is still an incurable disease, but progress made over the last ten years has led to a very considerable improvement in the range of available treatments to combat it. One of these promising drugs is called daratumumab.
• In Spain there are 40 new cases of multiple myelomaper million inhabitants each year.
Leukos Biotech, a biotechnology company founded by the Josep Carreras Leukemia Research Institute and by Dr. Ruth M. Risueño will develop a novel class of drugs around a newly discovered therapeutic target that selectively destroys Leukemia Stem Cells.
The third Saturday of each month of September we celebrate the World Blood Donor Day Marrow and Umbilical Cord Blood, an initiative of the World Marrow Donors Association (WMDA). Its a day to remind citizens around the world about the importance of donating bone marrow (hematopoietic stem cell or blood stem cells). (Available in Spanish).
